JohnPeterSfakianosMD

Surgical Oncology

Physician

Dr. Sfakianos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2012 - 2014
SUNY Downstate Health Sciences UniversityResidency, Urology, 2008 - 2012
SUNY Downstate Health Sciences UniversityInternship, Transitional Year, 2007 - 2008
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2007

PubMed

Immunotherapy-based neoadjuvant treatment and complication rates after radical cystectomy.
Reuben Ben-David, Francesco Pellegrino, Reza Mehrazin, Joel Thomas, Jack Geduldig
BJU International. 2025-01-23
2 citations
Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology.
Sandy Figiel, Anthony Bates, David A Braun, Renu Eapen, Markus Eckstein
European Urology. 2025-01-01
Editorial Commentary.
Ralph Grauer, John Sfakianos, Jeffrey A Stock
Urology Practice. 2025-01-01

Journal Articles

An Evaluation of Race, Ethnicity, Age, and Sex-Based Representation in Phase I to II Renal Cell Carcinoma Clinical Trials in the United States
Isuru Jayaratna, John P Sfakianos, Ketan K Badani, Urologic Oncology

An Evaluation of Race, Ethnicity, Age, and Sex-Based Representation in Phase I to II Renal Cell Carcinoma Clinical Trials in the United StatesJune 2018

New Approaches in the Bladder-Sparing ParadigmMarch 20th, 2023
Ask the Expert: John Sfakianos, M.D.June 17th, 2021
Novel Immune Checkpoint Axis to Understand BCG Resistance and Improve Treatment in Non-Muscle Invasive Bladder Cancer - Amir Horowitz & John SfakianosMay 10th, 2021
Join now to see all